1.
Hope TA,
Fowler KJ,
Sirlin CB,
et al.
Hepatobiliary agents and their role in LI-RADS.
Abdom Imaging [Internet].
2015 Mar 7
2.
Doo KW,
Lee CH,
Choi JW,
et al.
“Pseudo Washout” Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor.
Am J Roentgenol [Internet].
2009 Dec 23
3.
Kogita S,
Imai Y,
Okada M,
Kim T,
et al.
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
Eur Radiol [Internet].
2010 Oct 19
4.
Kumada T,
Toyoda H,
Tada T,
Sone Y,
et al.
Evolution of Hypointense Hepatocellular Nodules Observed Only in the Hepatobiliary Phase of Gadoxetate Disodium–Enhanced MRI.
Am J Roentgenol [Internet].
2011 Jul 23 [cited 2018 Dec 10];197(1):58–63.
5.
Motosugi U,
Ichikawa T,
Sano K,
Sou H,
et al.
Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease.
J Magn Reson Imaging [Internet].
2011 Jul
6.
Suh YJ,
Kim M-J,
Choi J-Y,
Park YN,
et al.
Differentiation of Hepatic Hyperintense Lesions Seen on Gadoxetic Acid–Enhanced Hepatobiliary Phase MRI.
Am J Roentgenol [Internet].
2011 Jul 23
7.
Venturi A,
Piscaglia F,
Vidili G,
et al.
Diagnosis and management of hepatic focal nodular hyperplasia.
J Ultrasound [Internet].
2007 Sep
8.
Van Kessel CS,
de Boer E,
ten Kate FJW,
et al.
Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI.
Abdom Imaging [Internet].
2013 Jun
9.
Stoot JHMB,
Coelen RJS,
De Jong MC,
Dejong CHC.
Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.
HPB (Oxford) [Internet].
2010 Oct
10.
Van Aalten SM,
de Man RA,
IJzermans JNM,
Terkivatan T.
Systematic review of haemorrhage and rupture of hepatocellular adenomas.
Br J Surg [Internet].
2012 Jul
11.
Guo Y,
Li W,
Cai W,
et al.
Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.
Int J Med Sci [Internet].
2017 [cited 2018 Dec 10];14(7):668–74.
12.
Tse JR,
Naini B V.,
Lu DSK,
Raman SS.
Qualitative and Quantitative Gadoxetic Acid–enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
Radiology [Internet].
2016 Apr 27
13.
Chu HH,
Moon WS.
β-catenin activated hepatocellular adenoma.
Clin Mol Hepatol [Internet].
2013 Jun [cited 2018 Dec 11];19(2):185–9.
14.
Khalaf AM,
Fuentes D,
Morshid AI,
et al.
Role of Wnt/β-catenin signaling in hepatocellular carcinoma,
pathogenesis,
and clinical significance.
J Hepatocell carcinoma [Internet].
2018
15.
Bioulac-Sage P,
Laumonier H,
Laurent C,
et al.
Hepatocellular adenoma: what is new in 2008.
Hepatol Int [Internet].
2008 Sep
16.
Katabathina VS,
Menias CO,
Shanbhogue AKP,
et al.
Genetics and Imaging of Hepatocellular Adenomas: 2011 Update.
RadioGraphics [Internet].
2011 Oct 4
17.
Vilgrain V,
Esvan M,
Ronot M,
et al.
A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
Eur Radiol [Internet].
2016 Dec 16
18.
Yu MH,
Lee JM,
Hur BY,
et al.
Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
Eur Radiol [Internet].
2015 Aug 23
19.
Kim HJ,
Lee SS,
Byun JH,
et al.
Incremental Value of Liver MR Imaging in Patients with Potentially Curable Colorectal Hepatic Metastasis Detected at CT: A Prospective Comparison of Diffusion-weighted Imaging,
Gadoxetic Acid–enhanced MR Imaging,
and a Combination of Both MR Techniques.
Radiology [Internet].
2015 Mar 3